Kaveri Pohlman
Stock Analyst at Clear Street
(2.55)
# 2,231
Out of 5,131 analysts
34
Total ratings
32.26%
Success rate
1.17%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kaveri Pohlman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RAPT RAPT Therapeutics | Downgrades: Hold | $60 → $58 | $57.72 | +0.49% | 3 | Jan 20, 2026 | |
| JANX Janux Therapeutics | Downgrades: Hold | $32 → $12 | $13.14 | -8.68% | 3 | Jan 20, 2026 | |
| PALI Palisade Bio | Initiates: Buy | $12 | $1.73 | +593.64% | 1 | Dec 30, 2025 | |
| GPCR Structure Therapeutics | Maintains: Buy | $61 → $99 | $70.07 | +41.29% | 1 | Dec 9, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $200 | $81.61 | +145.07% | 1 | Dec 5, 2025 | |
| JBIO Jade Biosciences | Initiates: Buy | $25 | $15.03 | +66.33% | 1 | Nov 25, 2025 | |
| TRVI Trevi Therapeutics | Maintains: Buy | $11 → $21 | $10.40 | +101.92% | 1 | Nov 14, 2025 | |
| ZURA Zura Bio | Initiates: Buy | $18 | $6.08 | +196.05% | 1 | Nov 13, 2025 | |
| SGMT Sagimet Biosciences | Initiates: Buy | $29 | $5.06 | +473.12% | 1 | Oct 22, 2025 | |
| VTYX Ventyx Biosciences | Initiates: Buy | $11 | $13.97 | -21.26% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 | $32.21 | +42.81% | 1 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $22.46 | +42.48% | 1 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.71 | - | 4 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $47 | $30.03 | +56.51% | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $30 | $11.59 | +158.84% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $56 → $38 | $11.60 | +227.59% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $5.77 | -13.34% | 2 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $1.30 | +515.38% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $43.92 | -38.52% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $18.92 | +269.98% | 1 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $3.86 | +210.88% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $8 | $5.32 | +50.38% | 2 | Jul 7, 2022 |
RAPT Therapeutics
Jan 20, 2026
Downgrades: Hold
Price Target: $60 → $58
Current: $57.72
Upside: +0.49%
Janux Therapeutics
Jan 20, 2026
Downgrades: Hold
Price Target: $32 → $12
Current: $13.14
Upside: -8.68%
Palisade Bio
Dec 30, 2025
Initiates: Buy
Price Target: $12
Current: $1.73
Upside: +593.64%
Structure Therapeutics
Dec 9, 2025
Maintains: Buy
Price Target: $61 → $99
Current: $70.07
Upside: +41.29%
Palvella Therapeutics
Dec 5, 2025
Initiates: Buy
Price Target: $200
Current: $81.61
Upside: +145.07%
Jade Biosciences
Nov 25, 2025
Initiates: Buy
Price Target: $25
Current: $15.03
Upside: +66.33%
Trevi Therapeutics
Nov 14, 2025
Maintains: Buy
Price Target: $11 → $21
Current: $10.40
Upside: +101.92%
Zura Bio
Nov 13, 2025
Initiates: Buy
Price Target: $18
Current: $6.08
Upside: +196.05%
Sagimet Biosciences
Oct 22, 2025
Initiates: Buy
Price Target: $29
Current: $5.06
Upside: +473.12%
Ventyx Biosciences
Oct 1, 2025
Initiates: Buy
Price Target: $11
Current: $13.97
Upside: -21.26%
Sep 17, 2025
Maintains: Buy
Price Target: $46
Current: $32.21
Upside: +42.81%
Jun 25, 2025
Initiates: Buy
Price Target: $32
Current: $22.46
Upside: +42.48%
Aug 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.71
Upside: -
Jun 27, 2024
Maintains: Buy
Price Target: $46 → $47
Current: $30.03
Upside: +56.51%
Apr 17, 2024
Maintains: Buy
Price Target: $20 → $30
Current: $11.59
Upside: +158.84%
Apr 16, 2024
Maintains: Buy
Price Target: $56 → $38
Current: $11.60
Upside: +227.59%
Mar 26, 2024
Upgrades: Buy
Price Target: $5
Current: $5.77
Upside: -13.34%
Feb 9, 2024
Initiates: Buy
Price Target: $8
Current: $1.30
Upside: +515.38%
Dec 19, 2023
Initiates: Buy
Price Target: $27
Current: $43.92
Upside: -38.52%
Aug 23, 2023
Reiterates: Buy
Price Target: $70
Current: $18.92
Upside: +269.98%
Aug 31, 2022
Initiates: Buy
Price Target: $12
Current: $3.86
Upside: +210.88%
Jul 7, 2022
Maintains: Buy
Price Target: $16 → $8
Current: $5.32
Upside: +50.38%